These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 19602719

  • 1. A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
    Bloomfield DM, Krishna R, Hreniuk D, Hickey L, Ghosh K, Bergman AJ, Miller J, Gutierrez MJ, Stoltz R, Gottesdiener KM, Herman GA, Wagner JA.
    J Clin Pharmacol; 2009 Aug; 49(8):937-46. PubMed ID: 19602719
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
    Iwamoto M, Kost JT, Mistry GC, Wenning LA, Breidinger SA, Marbury TC, Stone JA, Gottesdiener KM, Bloomfield DM, Wagner JA.
    J Clin Pharmacol; 2008 Jun; 48(6):726-33. PubMed ID: 18441333
    [Abstract] [Full Text] [Related]

  • 7. A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers.
    Radziszewski W, Lai E, Lazarus Shipitofsky N, Stroh M, Dishy V, Han L, Lewis W, Johnson-Levonas AO, Lutz R, Wagner J.
    Am J Ther; 2010 Jun; 17(1):8-16. PubMed ID: 20027105
    [Abstract] [Full Text] [Related]

  • 8. A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.
    Hug B, Abbas R, Leister C, Burns J, Sonnichsen D.
    Clin Cancer Res; 2010 Aug 01; 16(15):4016-23. PubMed ID: 20647478
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL, Zhang Y, Serra D, Wang Y, Ligueros-Saylan M, Dole WP.
    Curr Med Res Opin; 2011 Jul 01; 27(7):1453-63. PubMed ID: 21609207
    [Abstract] [Full Text] [Related]

  • 11. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.
    Kori S, Kellerman DJ, Voloshko P, Haugen G.
    Clin Ther; 2012 Sep 01; 34(9):1920-8. PubMed ID: 22917853
    [Abstract] [Full Text] [Related]

  • 12. Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects.
    Barriere S, Genter F, Spencer E, Kitt M, Hoelscher D, Morganroth J.
    J Clin Pharmacol; 2004 Jul 01; 44(7):689-95. PubMed ID: 15199073
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sitagliptin 100 mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement.
    Alba M, Sheng D, Guan Y, Williams-Herman D, Larson P, Sachs JR, Thornberry N, Herman G, Kaufman KD, Goldstein BJ.
    Curr Med Res Opin; 2009 Oct 01; 25(10):2507-14. PubMed ID: 19691426
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Davy M, Upward J, Arumugham T, Twomey C, Chen C, Stier B.
    Clin Ther; 2013 Dec 01; 35(12):1964-74. PubMed ID: 24290737
    [Abstract] [Full Text] [Related]

  • 19. Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects.
    Ayalasomayajula S, Yeh CM, Vaidyanathan S, Flannery B, Dieterich HA, Howard D, Bedigian MP, Dole WP.
    J Clin Pharmacol; 2008 Jul 01; 48(7):799-811. PubMed ID: 18490495
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.